Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0.385. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →In8Bio, Inc.
Grant: F31NS124130
In8Bio, Inc.
Grant: F99NS129129
In8Bio, Inc.
Grant: 1R03NS128449-01S1
NIH HHS
Grant: 1F99NS129129-01A1
Aberrant Signaling from Brain Tumors Regulates Distant and Local Environments
NINDS NIH HHS
Grant: K00 NS129129
NCI NIH HHS
Grant: P30 CA013148
NIH HHS
Grant: 1F31NS124130-01A1
Restoring the Sphingolipid Balance in Glioblastoma
University of Alabama at Birmingham
Grant: Start Up Funds
NINDS NIH HHS
Grant: R03 NS128449
In8Bio, Inc
Grant: NA
National Institutes of Health
Grant: 2P30CA013148-34
TISSUE PROCUREMENT
National Institutes of Health
Grant: 1R03NS128449-01
Targeting Acid Ceramidase to Improve the Efficacy of Herpes Oncolytic Virus
FWCI
3.85
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals